BSE - Delayed Quote INR

Bharat Parenterals Ltd (BPLPHARMA.BO)

1,293.60
-26.35
(-2.00%)
At close: 3:15:00 PM GMT+5:30
Loading Chart for BPLPHARMA.BO
  • Previous Close 1,319.95
  • Open 1,293.60
  • Bid --
  • Ask 1,293.60 x --
  • Day's Range 1,293.60 - 1,293.60
  • 52 Week Range 802.00 - 1,590.00
  • Volume 207
  • Avg. Volume 2,950
  • Market Cap (intraday) 8.915B
  • Beta (5Y Monthly) 0.74
  • PE Ratio (TTM) --
  • EPS (TTM) -66.66
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 1.00 (0.08%)
  • Ex-Dividend Date Jun 25, 2024
  • 1y Target Est --

Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India. The company provides products in the areas of antibiotics, anti-retroviral, antiprotozoal/anthelmintic, respiratory, antiallergic/anti-histaminic/anticold, cleansing agents/skin infections, cardiovascular systems, anti-diabetic, anti-tuberculosis, anti-fungal, antimalarial, gastrointestinal tract/alimentary systems, anti-inflammatory/anti-pyretic/analgesics, supplements, central nervous system, anaesthetics, anti-viral, steroids and hormones, uterine stimulant, anticancer, and others. It also provides general products, ß-lactum /cephalosporin products, and formulations. The company offers its products in the form of tablets, capsules, liquid-orals, ointments, creams, lotions, suspensions, syrups, powders, oral solutions and drops, gels, vaginal inserts, nebulizers, elixiers, eye drops, infusions, nasal drops, and powdered injections, as well as in ampoules and vials. It serves biopharmaceuticals startup and pharmaceutical companies. The company also exports its products internationally. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.

bplindia.in

--

Full Time Employees

March 31

Fiscal Year Ends

Recent News: BPLPHARMA.BO

View More

Performance Overview: BPLPHARMA.BO

Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

BPLPHARMA.BO
11.87%
S&P BSE SENSEX (^BSESN)
5.44%

1-Year Return

BPLPHARMA.BO
18.64%
S&P BSE SENSEX (^BSESN)
7.72%

3-Year Return

BPLPHARMA.BO
18.64%
S&P BSE SENSEX (^BSESN)
51.72%

5-Year Return

BPLPHARMA.BO
18.64%
S&P BSE SENSEX (^BSESN)
140.58%

Compare To: BPLPHARMA.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: BPLPHARMA.BO

View More

Valuation Measures

Annual
As of 6/9/2025
  • Market Cap

    9.10B

  • Enterprise Value

    10.22B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.67

  • Price/Book (mrq)

    2.75

  • Enterprise Value/Revenue

    3.00

  • Enterprise Value/EBITDA

    71.36

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.71%

  • Return on Assets (ttm)

    -3.54%

  • Return on Equity (ttm)

    -15.14%

  • Revenue (ttm)

    3.4B

  • Net Income Avi to Common (ttm)

    -126.3M

  • Diluted EPS (ttm)

    -66.66

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    679.9M

  • Total Debt/Equity (mrq)

    53.16%

  • Levered Free Cash Flow (ttm)

    -571.5M

Research Analysis: BPLPHARMA.BO

View More

Company Insights: BPLPHARMA.BO

Research Reports: BPLPHARMA.BO

View More

People Also Watch